Patent Licensing USA June 21, 2023 Washington DC

Patent Licensing USA

June 21, 2023

Washington DC

Effective & Practical Strategies for the Patent Licensing Lifecycle

Registration closes in:

DAYS

HOURS

MINUTES

SECONDS

100

Attendees

Speakers

Hours Content

Bloom Energy and Miles & Stockbridge join the programme for Patent Licensing USA!

Unlock key considerations in monetization and licensing strategy for patent owners.

Patent monetization is a key theme throughout the conference, and we're pleased to announce Thomas Hassing, Vice President of Intellectual Property at Bloom Energy, and Andrew Wahba, Principal at Miles & Stockbridge have just joined the speaker faculty to take a deep dive into the key considerations in monetization and licensing strategy for patent owners.

Andrew and Thomas join an outstanding lineup of speakers from a great range of patent-owning companies and licensing practitioners including:

Kayleigh Nauman

IP Attaché - Trade and Agriculture

British Embassy, Washington, DC

Kelly Morgan

VP, Head of IP and Legal

Arbor Biotechnologies

Paul Coletti

VP, MedTech IP Strategy

Johnson & Johnson

Peng Sun

Senior Director, Senior Patent Counsel

Sarepta Therapeutics

Elaine Drager

Strategic Partnerships and Technology Leadership Office Lead Counsel

Nokia

Brian Hinman

Chief Commercial Officer

Aon

Jaime Siegel

Head of Global Licensing

Open Invention Network

Ken Corsello

US Trade Secrets Counsel / Patent Licensing Counsel

IBM Corporation

Tulip Mahaseth

Director, Intellectual Property & Corporate Counsel

4D Molecular Therapeutics

Saira Haider

SVP of Strategic Partnerships

RxCap

Andrew Wahba

Principal

Miles & Stockbridge

Margaret Sampson

Partner

McDermott Will & Emery

Richard Berman

Partner

ArentFox Schiff

Vishal Amin

Head of IP Policy

Intel

Andrew Remes

Licensing Manager - Life Sciences

University of Pittsburgh

Joe Mahoney

Partner

Mayer Brown

Nicole Mastrangelo

Staff Attorney, IP

Beam TX

Ajay Rastogi

Director of Business Development & Licensing Advanced Genomics

Millipore Sigma

Join The Conversation! #PatentLicensingUSA

What’s different about Patent Licensing USA?

Patent Licensing USA covers the whole licensing agreement lifecycle—in one place and over the course of just one day.

It focuses purely on patent licensing—so every single session is relevant to patent licensing attorneys.

At least half of our delegates are in-house counsel from tech, pharma and biotech companies, enabling real collaboration between in-house and private practice licensing attorneys.